Radiation is commonly used to kill cancer cells and shrink tumours. Stereotactic Body Radiation Therapy (SBRT) is used to treat cancers using substantially higher doses of radiation than conventional radiotherapy. This technology is able to deliver higher doses of radiation to a tumour, while limiting the dose of radiation to nearby normal tissues.
SBRT is commonly employed in cancers of the lung, liver, and pancreas, where it is used to shrink tumours that have spread to other parts of the body.
The purpose of this trial is to access the safety and effectiveness of giving five rounds of SBRT to patients with advanced kidney cancer.
Patients on this trial will complete quality of life questionnaires for up to five years after treatment.
- Any Subtype
- Advanced kidney cancer that cannot be removed by surgery
- Only tumours over 2.5cm in diameter are eligible for SBRT
Additional eligibility criteria will apply. Please speak to your doctor.Find out more about this study.
|Hospital / Cancer Centre||Principal Investigator||Location||Trial Status|
|Hospital / Cancer CentreOdette Cancer Centre||Principal InvestigatorDr. William Chu||LocationToronto, ON||Trial StatusRecruiting|
|Hospital / Cancer CentreJuravinski Cancer Centre||Principal InvestigatorDr. Anand Swaminath||LocationHamilton, ON||Trial StatusRecruiting|